Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: symptomatic cardiac obstruction–pilot study of enalapril in aortic stenosis (SCOPE-AS)
Open Access
- 30 April 2004
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 147 (4), 740
- https://doi.org/10.1016/j.ahj.2003.10.017
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Cardiac HypertrophyPublished by Wiley ,2006
- Progression From Compensated Hypertrophy to Failure in the Pressure-Overloaded Human HeartCirculation, 2003
- ACE inhibition in aortic stenosis: dangerous medicine or golden opportunity?Journal of Human Hypertension, 2001
- Differential Suppression of Pressure-Overload Cardiac and Aortic Hypertrophy in Rats by Angiotensin-Converting Enzyme InhibitorsThe Japanese Journal of Pharmacology, 1999
- Blockade of the Renin-Angiotensin System in Cardiac Pressure-Overload Hypertrophy in RatsHypertension, 1995
- Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection FractionsNew England Journal of Medicine, 1992
- Effects of the Early Administration of Enalapril on Mortality in Patients with Acute Myocardial InfarctionNew England Journal of Medicine, 1992
- Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation.Journal of Clinical Investigation, 1990
- Angiotensin II: Hemodynamic regulator or growth factor?Journal of Molecular and Cellular Cardiology, 1990
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987